Breaking News Instant updates and real-time market news.

GME

GameStop

$3.40 /

-0.16 (-4.49%)

, XBIT

XBiotech

$12.73 /

-0.3 (-2.30%)

08:45
02/27/20
02/27
08:45
02/27/20
08:45

Largest borrow rate increases among liquid names

Latest data shows the largest indicative borrow rate increases among liquid option names include: GameStop (GME) 18.78% +1.56, XBiotech (XBIT) 23.64% +0.94, Alpha Pro Tech (APT) 41.44% +0.78, California Resources (CRC) 24.94% +0.60, Frontier Communications (FTR) 99.04% +0.58, Chesapeake (CHK) 1.00% +0.35, Direxion Daily S&P Bull (SPXL) 1.63% +0.28, PPL Corp. (PPL) 0.44% +0.19, Ballard Power (BLDP) 39.45% +0.18, and Novavax (NVAX) 62.81% +0.17.

GME

GameStop

$3.40 /

-0.16 (-4.49%)

XBIT

XBiotech

$12.73 /

-0.3 (-2.30%)

APT

Alpha Pro Tech

$12.41 /

+2.5 (+25.23%)

CRC

California Resources

$6.27 /

-0.5 (-7.39%)

FTR

Frontier Communications

$0.52 /

-0.0257 (-4.67%)

CHK

Chesapeake

$0.31 /

-0.1412 (-31.38%)

PPL

PPL Corp.

$33.26 /

-1.3 (-3.76%)

BLDP

Ballard Power

$10.50 /

-0.65 (-5.83%)

NVAX

Novavax

$9.22 /

+1.26 (+15.83%)

  • 01

    Mar

  • 02

    Mar

  • 05

    Mar

  • 13

    Mar

GME GameStop
$3.40 /

-0.16 (-4.49%)

02/13/20 Maxim
Turtle Beach price target lowered to $16 from $22 at Maxim
01/14/20 Loop Capital
GameStop holiday sales miss driven by hardware decline, says Loop Capital
01/07/20 BofA
Aaron's, Lowe's positioned for outperformance in 2020, says BofA
12/11/19 Baird
Baird cuts GameStop price target to $5 after 'double whammy' Q3
XBIT XBiotech
$12.73 /

-0.3 (-2.30%)

12/11/19 Piper Sandler
XBiotech price target raised to $28 from $16 at Piper Jaffray
11/13/19 Piper Sandler
XBiotech price target raised to $16 from $13 at Piper Jaffray
06/14/19 Piper Sandler
XBiotech initiated with an Overweight at Piper Jaffray
APT Alpha Pro Tech
$12.41 /

+2.5 (+25.23%)

CRC California Resources
$6.27 /

-0.5 (-7.39%)

08/05/19 Imperial Capital
California Resources price target lowered to $20 from $28 at Imperial Capital
05/13/19
California Resources upgraded to Outperform on valuation at Raymond James
05/13/19 Raymond James
California Resources upgraded to Outperform at Raymond James
04/12/19 Goldman Sachs
Goldman downgrades California Resources, Chesapeake to Sell, upgrades Murphy
FTR Frontier Communications
$0.52 /

-0.0257 (-4.67%)

06/20/19 Citi
Frontier Communications price target lowered to $1.00 from $1.50 at Citi
CHK Chesapeake
$0.31 /

-0.1412 (-31.38%)

12/09/19 Imperial Capital
Chesapeake price target lowered to 50c from $2 at Imperial Capital
12/09/19 Imperial Capital
Chesapeake price target lowered to 50c from $2 at Imperial Capital
11/26/19 Scotiabank
Chesapeake upgraded to Outperform from Sector Perform at Scotiabank
11/19/19 Johnson Rice
Chesapeake downgraded to Hold from Accumulate at Johnson Rice
PPL PPL Corp.
$33.26 /

-1.3 (-3.76%)

01/10/20 Argus
PPL Corp. price target raised to $39 from $34 at Argus
01/08/20
Fly Intel: Top five analyst upgrades
01/08/20 Guggenheim
Guggenheim changes eight ratings, names Exelon best idea in 2020 Utility outlook
01/07/20 Guggenheim
PPL Corp. upgraded to Buy from Neutral at Guggenheim
BLDP Ballard Power
$10.50 /

-0.65 (-5.83%)

11/01/19 Lake Street
Ballard Power price target raised to $6 from $5 at Lake Street
11/01/19 H.C. Wainwright
Ballard Power downgraded to Neutral from Buy at H.C. Wainwright
07/01/19
Ballard Power downgraded to Sell on valuation at Roth Capital
07/01/19 Roth Capital
Ballard Power downgraded to Sell from Neutral at Roth Capital
NVAX Novavax
$9.22 /

+1.26 (+15.83%)

02/26/20 Ladenburg
Investors right to buy up Novavax today on COVID-19 plans, says Ladenburg
01/27/20 Ladenburg
Novavax platform ideally suited for pandemic flu outbreaks, says Ladenburg
01/22/20 H.C. Wainwright
Novavax coronavirus results could be catalyst in Q1, says H.C. Wainwright
11/27/19 B. Riley FBR
Novavax resumed with a Buy at B. Riley FBR

TODAY'S FREE FLY STORIES

Hot Stocks
Macau reports March casino revenue down 79.7% to 5.257B patacas » 06:27
04/01/20
04/01
06:27
04/01/20
06:27
LVS

Las Vegas Sands

$42.32 /

-1.17 (-2.69%)

, MGM

MGM Resorts

$11.80 /

+0.26 (+2.25%)

, WYNN

Wynn Resorts

$60.02 /

-1.07 (-1.75%)

, MLCO

Melco Resorts & Entertainment

$12.41 /

-0.085 (-0.68%)

Macau's gaming…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Dollar Tree upgraded to Buy from Neutral at Citi » 06:26
04/01/20
04/01
06:26
04/01/20
06:26
DLTR

Dollar Tree

$73.48 /

-6.33 (-7.93%)

Citi analyst Paul Lejuez…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Trane downgraded to Neutral from Buy at BofA » 06:26
04/01/20
04/01
06:26
04/01/20
06:26
TT

Trane

$82.52 /

-1.33 (-1.59%)

BofA analyst Andrew Obin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
D.R. Horton upgraded to Outperform from Neutral at Wedbush » 06:25
04/01/20
04/01
06:25
04/01/20
06:25
DHI

D.R. Horton

$34.00 /

-2.91 (-7.88%)

Wedbush analyst Jay…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
HD Supply downgraded to Neutral from Buy at Longbow » 06:25
04/01/20
04/01
06:25
04/01/20
06:25
HDS

HD Supply

$28.45 /

+0.81 (+2.93%)

Longbow analyst Chris…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Dollar General assumed with a Buy at Citi » 06:24
04/01/20
04/01
06:24
04/01/20
06:24
DG

Dollar General

$151.27 /

+4.66 (+3.18%)

Citi analyst Paul Lejuez…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Akorn says 'no longer has any bids that are sufficient to pay all obligations' » 06:24
04/01/20
04/01
06:24
04/01/20
06:24
AKRX

Akorn

$0.56 /

-0.0849 (-13.16%)

Akorn, announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Astec upgraded to Outperform from Neutral at Baird » 06:24
04/01/20
04/01
06:24
04/01/20
06:24
ASTE

Astec

$34.84 /

+2.38 (+7.33%)

Baird analyst Mircea…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
KKR postpones plan to sell Goodpack amid COVID-19 pandemic, Reuters reports » 06:23
04/01/20
04/01
06:23
04/01/20
06:23
KKR

KKR

$23.50 /

-1.02 (-4.16%)

KKR has put off a plan to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Dollar Tree downgraded to Market Perform from Outperform at Telsey Advisory » 06:23
04/01/20
04/01
06:23
04/01/20
06:23
DLTR

Dollar Tree

$73.48 /

-6.33 (-7.93%)

Telsey Advisory analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Eidos Therapeutics resumed with a Neutral at BofA » 06:22
04/01/20
04/01
06:22
04/01/20
06:22
EIDX

Eidos Therapeutics

$48.86 /

-0.04 (-0.08%)

BofA analyst Geoff…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
TSMC on track to move 5nm technology to volume production in Q2, DigiTimes says » 06:22
04/01/20
04/01
06:22
04/01/20
06:22
TSM

TSMC

$47.79 /

-0.04 (-0.08%)

, AAPL

Apple

$254.28 /

-0.61 (-0.24%)

TSMC (TSM) is on track to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Denny's upgraded to Buy from Hold at SunTrust » 06:21
04/01/20
04/01
06:21
04/01/20
06:21
DENN

Denny's

$7.68 /

-0.17 (-2.17%)

SunTrust analyst Jake…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
SoftBank-backed Oyo furloughs most of its U.K. staff, Yahoo Finance reports » 06:20
04/01/20
04/01
06:20
04/01/20
06:20
SFTBF

Use SFTBY

$0.00 /

+ (+0.00%)

, SFTBY

SoftBank

$0.00 /

+ (+0.00%)

SoftBank-backed hotel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
El Pollo Loco upgraded to Buy from Hold at SunTrust » 06:20
04/01/20
04/01
06:20
04/01/20
06:20
LOCO

El Pollo Loco

$8.46 /

+0.46 (+5.75%)

SunTrust analyst Jake…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
BioXcel Therapeutics initiated with a Buy at BofA » 06:19
04/01/20
04/01
06:19
04/01/20
06:19
BTAI

BioXcel Therapeutics

$22.40 /

-1.96 (-8.05%)

BofA analyst Geoff…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Kansas City Southern downgraded to Neutral from Buy at UBS » 06:19
04/01/20
04/01
06:19
04/01/20
06:19
KSU

Kansas City Southern

$127.15 /

-2.11 (-1.63%)

UBS analyst Thomas…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Epizyme downgraded to Perform from Outperform at Oppenheimer » 06:18
04/01/20
04/01
06:18
04/01/20
06:18
EPZM

Epizyme

$15.41 /

-1.12 (-6.78%)

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
ShockWave Medical downgraded to Underperform from Perform at Oppenheimer » 06:17
04/01/20
04/01
06:17
04/01/20
06:17
SWAV

ShockWave Medical

$33.11 /

-2.86 (-7.95%)

Oppenheimer analyst Suraj…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Crispr Therapeutics study halts not unexpected, says Piper Sandler » 06:17
04/01/20
04/01
06:17
04/01/20
06:17
CRSP

Crispr Therapeutics

$42.26 /

-2.08 (-4.69%)

Crispr Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Crispr Therapeutics says has closed offices, request personnel work remotely » 06:16
04/01/20
04/01
06:16
04/01/20
06:16
CRSP

Crispr Therapeutics

$42.26 /

-2.08 (-4.69%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Atmos Energy upgraded to Buy from Neutral at UBS » 06:16
04/01/20
04/01
06:16
04/01/20
06:16
ATO

Atmos Energy

$99.44 /

-3.53 (-3.43%)

UBS analyst Aga…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Crispr Therapeutics says business may be adversely affected by pandemic » 06:15
04/01/20
04/01
06:15
04/01/20
06:15
CRSP

Crispr Therapeutics

$42.26 /

-2.08 (-4.69%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Intuitive Surgical downgraded to Underperform from Perform at Oppenheimer » 06:13
04/01/20
04/01
06:13
04/01/20
06:13
ISRG

Intuitive Surgical

$495.27 /

-8.98 (-1.78%)

Oppenheimer analyst Suraj…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
CenterPoint Energy downgraded to Neutral from Buy at UBS » 06:13
04/01/20
04/01
06:13
04/01/20
06:13
CNP

CenterPoint Energy

$15.44 /

-0.79 (-4.87%)

UBS analyst Aga…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.